DRUG DEVELOPMENT PROFITS WOULD INCREASE LESS THAN 3% ON AVERAGE UNDER CLINTON HEALTH SECURITY ACT, CBO REPORT FINDS; TOTAL DRUG DEMAND WOULD RISE 4%-6%
Executive Summary
Drug industry profitability would rise less than 3% on average under President Clinton's Health Security Act, the Congressional Budget Office concludes in a newly released report entitled How Health Care Reform Affects Pharmaceutical Research and Development.